Epigenetic mechanisms of rapid-acting antidepressants
Open accessThe DOI matches its Crossref record; 270 of the 272 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Rapid-acting antidepressants (RAADs), including dissociative anesthetics, psychedelics, and empathogens, elicit rapid and sustained therapeutic improvements in psychiatric disorders by purportedly modulating neuroplasticity, neurotransmission, and immunity. These outcomes may be mediated by, or result in, an acute and/or sustained entrainment of epigenetic processes, which remodel chromatin structure and alter DNA accessibility to regulate gene expression. METHODS: In this perspective, we present an overview of the known mechanisms, knowledge gaps, and future directions surrounding the epigenetic effects of RAADs, with a focus on the regulation of stress-responsive DNA and brain regions, and on the comparison with conventional antidepressants. MAIN BODY: Preliminary correlative evidence indicates that administration of RAADs is accompanied by epigenetic effects which are similar to those elicited by conventional antidepressants. These include changes in DNA methylation, post-translational modifications of histones, and differential regulation of non-coding RNAs in stress-responsive chromatin areas involved in neurotrophism, neurotransmission, and immunomodulation, in stress-responsive brain regions. Whether these epigenetic changes causally contribute to the therapeutic effects of RAADs, are a consequence thereof, or are unrelated, remains unknown. Moreover, the potential cell type-specificity and mechanisms involved are yet to be fully elucidated. Candidate mechanisms include neuronal activity- and serotonin and Tropomyosine Receptor Kinase B (TRKB) signaling-mediated epigenetic changes, and direct interaction with DNA, histones, or chromatin remodeling complexes. CONCLUSION: Correlative evidence suggests that epigenetic changes induced by RAADs accompany therapeutic and side effects, although causation, mechanisms, and cell type-specificity remain largely unknown. Addressing these research gaps may lead to the development of novel neuroepigenetics-based precision therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, ketamine reduces the hypermethylation of the BDNF gene promoter, a process often heightened in stress-related conditions, thereby enhancing BDNF transcription and promoting neuroplasticity [64].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–270 of 270
Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression
Ryan, J., Pilkington, L., Neuhaus, K., Ritchie, K., Ancelin, M.-L., & Saffery, R. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1515-8 · Cited by 40
Roy, B., Wang, Q., & Dwivedi, Y. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy010 · Cited by 39
Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
Simonsson, O., Hendricks, P. S., Carhart-Harris, R. L., Kettner, H., & Osika, W. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16715 · Cited by 39 · cited 1×
“However, subsequent experimental and epidemiological studies failed to replicate the fi ndings, even in long-term psychedelic users [261, 262].”
BackgroundEl-Saiy, K. A., Sayed, R. H., El-Sahar, A. E., & Kandil, E. A. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.109841 · Cited by 39
Ling, Y., Feng, J., Luo, L., Guo, J., Peng, Y., Wang, T., Ge, X., Xu, Q., Wang, X., Dai, H., et al. (2017) · ChemMedChem · doi:10.1002/cmdc.201700133 · Cited by 38 · cited 1×
“The β -carbolines contained in the Ayahuasca brew might also inhibit histone deacetylase activity, given that engineered derivatives containing β -carbolines motifs are potent HDACs inhibitors [81, 82].”
BackgroundAgRP neurons coordinate the mitigation of activity-based anorexia
Hickey, A. K. S., Duane, S. C., Mickelsen, L. E., Karolczak, E. O., Shamma, A. M., Skillings, A., Li, C., & Krashes, M. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01932-w · Cited by 38
Jiang, X., Du, B., Chen, J., Liu, L., Shao, W.-B., & Song, J. (2014) · PubMed Central · Cited by 36
Goswami, A., Mukherjee, K., Mazumder, A., Ganguly, S., Mukherjee, I., Chakrabarti, S., Roy, S., Sundar, S., Chattopadhyay, K., & Bhattacharyya, S. N. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911011 · Cited by 36 · cited 1×
“Ketamine also decreased miR-451 levels and increased those of the RNA-binding protein hur-6, a de-repressor miRNA “ sponge ” for deleterious miRNAs involved in in fl ammatory responses [124, 145, 146].”
BackgroundImmunoregulation and antidepressant effect of ketamine
Zhang, N., Yao, L., Wang, P., & Liu, Z. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0167 · Cited by 36 · cited 1×
“Ketamine also elicited immunomodulatory prophylactic effects in lipopolysaccharide (LPS)-treated mice through miR-149 [152], indicating that some of the immunomodulatory effects of ketamine involved in its antidepressant effects [153] might be mediated by ncRNAs.”
BackgroundZeifman, R. J., Yu, D., Singhal, N., Wang, G., Nayak, S. M., & Weissman, C. R. (2022) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.21r14057 · Cited by 35 · cited 1×
“Despite the fact that the use of RAADs has been associated with decreased likelihood of suicide [75, 76], DNA hypermethylation is also observed in the blood of individuals who attempted suicide [77] and in the PFC of suicide completers [78].”
BackgroundSerotonin Receptor 5-HT2A Regulates TrkB Receptor Function in Heteroreceptor Complexes
Ilchibaeva, T., Tsybko, A., Zeug, A., Müller, F. E., Guseva, D., Bischoff, S., Ponimaskin, E., & Naumenko, V. (2022) · Cells · doi:10.3390/cells11152384 · Cited by 35 · cited 1×
“Lastly, given that (i) psyche-delics interact with TRKB, 5-HT 2A , and mGlu2 receptors, that (ii) TRKB interacts with the 5-HT 2A [193] and the mGlu2 [194] receptors, and that (iii) the latter two receptors interact with each other [195], these interactions may be functionally relevant from an…”
BackgroundThe role of miR-124 in modulating hippocampal neurotoxicity induced by ketamine anesthesia
Xu, H., Zhang, J., Zhou, W. J., Feng, Y., Teng, S., & Song, X. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.919915 · Cited by 34 · cited 3×
“Additionally, repeated high-dose ketamine in young mice led to neurotoxicity, neuronal degeneration and memory impairments during adulthood, at least partially through miR-34c [236], miR-124 [237], miR-137 [238], and miR-199a-5p [239] signaling.”
BackgroundValproate augmentation in a subgroup of patients with treatment-resistant unipolar depression
Ghabrash, M. F., Comai, S., Tabaka, J. M., Saint-Laurent, M., Booij, L., & Gobbi, G. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1073856 · Cited by 33 · cited 1×
“Epigenetically-active compounds with DNA demethylase activity [45] have antidepressant effects [46, 47], con fi rming that the methylation state and the associated psychiatric symptoms can be reversed pharmacologically [48].”
BackgroundLewis, C. R., Tafur, J., Spencer, S., Green, J. M., Harrison, C., Kelmendi, B., Rabin, D. M., Yehuda, R., Yazar‐Klosinski, B., & Cahn, B. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.959590 · Cited by 33 · cited 3×
“…samples correlates with symptom reduction in individuals with severe PTSD receiving MDMA-assisted psychotherapy A modulation of DNA methylation in stress-responsive genomic regions might be involved in the therapeutic effects of MDMA-assisted psychotherapy in individuals with severe PTSD [83]”
BackgroundInfluentialThe role of Ca2+-signaling in the regulation of epigenetic mechanisms
Hernández‐Oliveras, A., & Zarain‐Herzberg, Á. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102836 · Cited by 33
Qiao, M., Jiang, Q.-S., Liu, Y.-J., Hu, X.-Y., Wang, L.-J., Zhou, Q.-X., & Qiu, H.-M. (2019) · NeuroReport · doi:10.1097/wnr.0000000000001191 · Cited by 31 · cited 1×
“…H3 lysine (K)9 and H3K27) hypoacetylation of the BDNF promoters, reverse the stress-induced decrease in BDNF transcription and protein level, promote HDAC5 phosphorylation and nuclear export, and attenuate the stress-induced increase in HDACs in stress-susceptible brain areas [1, 55, 84, 88 – 92].”
BackgroundEffects of rhynchophylline on the hippocampal miRNA expression profile in ketamine-addicted rats
Li, C., Tu, G., Luo, C., Guo, Y., Fang, M., Zhu, C. Y., Li, H., Ou, J., Zhou, Y., Liu, W., et al. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.02.009 · Cited by 30 · cited 3×
“…general consensus that psychedelics have low potential for addiction, psychological dependence or reinforcing effects, the NMDA antagonist ketamine [225, 226] and the empathogen MDMA [227, 228] have been associated with drug-seeking behaviors accompanied by epigenetic changes, similarly to drugs…”
BackgroundInfluentialZhao, X., Shu, F., Wang, X., Wang, F., Wu, L., Li, L., & Lv, H. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.035 · Cited by 30 · cited 2×
“Speci fi c miRNAs are involved in the in vitro neurotoxic effects of ketamine at higher doses [215] Ketamine exposure in CA1 hippocampal cell cultures increases miR-124 expression. miR-124 inhibition partially decreases the ketamine-induced neurotoxicity and upregulates the expression of AMPA,…”
BackgroundThe Mutagenic Consequences of DNA Methylation within and across Generations
Hanson, H. E., & Liebl, A. L. (2022) · Epigenomes · doi:10.3390/epigenomes6040033 · Cited by 30 · cited 1×
“Given that cytosine methylation can affect the likelihood of mutations [73, 74] future studies are warranted to investigate the potential effects of the increased DNA methylation elicited by LSD on genomic stability and mutation rates.”
BackgroundmiR-98-5p plays a critical role in depression and antidepressant effect of ketamine
Huang, C., Wang, Y. Y., Wu, Z., Xu, J., Zhou, L., Wang, D., Yang, L., Zhu, B., Chen, G., Liu, C., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01588-0 · Cited by 30
Upregulation of miR-137 protects anesthesia-induced hippocampal neurodegeneration.
Huang, C., Zhang, X., Zheng, J., Chen, C., Chen, Y., & Yi, J. (2014) · Europe PMC (PubMed Central) · Cited by 29
Nghia, N. A., Hirasawa, T., Kasai, H., Obata, C., Moriishi, K., Mochizuki, K., Koizumi, S., & Kubota, T. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.010 · Cited by 29
Li, H., Li, C., Zhou, Y., Luo, C., Ou, J.-Y., Li, J., & Mo, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5814 · Cited by 29 · cited 2×
“…expression of 34 hippocampal miRNAs [225], while another study showed that the conditioned place preference was accompanied by altered expression of serum exosomal miRNAs associated with processes such as nervous system development, neuron generation and differentiation, and apoptosis [231].”
BackgroundHibicke, M., Kramer, H. M., & Nichols, C. D. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0012 · Cited by 29 · cited 1×
“Accordingly, a single administration of psilocybin following chronic stress during adolescence in rats was suf fi cient to normalize depressive-like and cognitive-like behaviors [192].”
BackgroundEngelmann, J., Zillich, L., Frank, J., Wagner, S., Cetin, M., Herzog, D. P., Müller, M. B., Tadic, A., Foo, J. C., Sirignano, L., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02032-7 · Cited by 29 · cited 1×
“Identifying predictors [266] and modulators (i.e., set and setting, placebo effect) [267] of epigenetic responses accompanying RAADs administration could lead to improved therapeutic precision and ef fi cacy.”
Backgroundde Oliveira, C. D. R., Moreira, C. Q., Spinosa, H. D. S., & Yonamine, M. (2011) · Revista Brasileira de Farmacognosia · doi:10.1590/s0102-695x2011005000170 · Cited by 28
Caputi, F. F., Palmisano, M., Carboni, L., Candeletti, S., & Romualdi, P. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.023 · Cited by 27 · cited 3×
“…upregulates the DYN system and downregulates the N/OFQ system via modulating histone PTMs in promoter DNA regions in the nucleus accumbens [232] Chronic MDMA leads to cardiac gene promoters hypermethylation and circadian-related gene expression changes, coupled to cardiac hypertrophy and…”
BackgroundInfluentialSelf-citationYao, Y., Wang, X., & Gao, J. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s256319 · Cited by 27 · cited 2×
“Repeated high-dose ketamine also elicited schizophrenia-like behavior accompanied by modulation of the miRNome and neurotrophic-related gene expression in the PFC and hippocampus [242, 243].”
BackgroundChuang, S., Lu, J., Lin, K., Long, C., Lee, Y., Hsiao, H., Tsai, C., Wu, W., Yang, H., & Juan, Y. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4252 · Cited by 25
Brown, I. R. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.837 · Cited by 24 · cited 1×
“The increased histone acetylation activity elicited by LSD suggests gene activation, and indeed, LSD activates the transcription [99] of immediate early genes and genes involved with synaptic potentiation and neurotropism in the hippocampus, cortex, midbrain [100], and brainstem [99].”
BackgroundLiu, R., Wu, X., He, X., Wang, R.-Z., Yin, X., Zhou, F., Ji, M., & Shen, J.-C. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.173079 · Cited by 24 · cited 2×
“It also restored the decrease in hippocampal total BDNF and BDNF exon I transcription and protein levels [52].”
BackgroundLysergic Acid Diethylamide: Effect on Histone Acetylation in Rabbit Brain
Brown, I. R., & Liew, C. C. (1975) · Science · doi:10.1126/science.1215990 · Cited by 23 · cited 2×
“Early studies reported that LSD acutely increases histone acetylation in the midbrain and cortex, but not the cerebellum of rabbits [98].”
BackgroundKoczor, C. A., Ludlow, I., Hight, R. S., Jiao, Z., Fields, E. J., Ludaway, T., Russ, R. B., Torres, R. A., & Lewis, W. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv170 · Cited by 23 · cited 3×
“…promoters hypermethylation and circadian-related gene expression changes, coupled to cardiac hypertrophy and progressive damage MDMA abuse affects cardiac DNA methylation, and this might be involved in cardiotoxicity [217] and in vitro, while increasing BDNF and decreasing apoptosis [147 – 149].”
BackgroundLysergic Acid Diethylamide (LSD) Binding to Deoxyribonucleic Acid (DNA)
Yielding, K. L., & Sterglanz, H. (1968) · Experimental Biology and Medicine · doi:10.3181/00379727-128-33303 · Cited by 23 · cited 2×
“Indeed, the β -carbolines contained in the brew Ayahuasca directly interact with DNA in vitro [196], and early studies observed that LSD directly binds DNA or histone proteins [197 – 199].”
BackgroundKato, M., Ogata, H., Tahara, H., Shimamoto, A., Takekita, Y., Koshikawa, Y., Nishida, K., Nonen, S., Higasa, K., & Kinoshita, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073873 · Cited by 23 · cited 1×
“Similarly to what observed with conventional antidepressants [140, 154 – 159] the miRNome might predict the therapeutic response elicited by RAADs.”
ResultPermissive Group Therapy with Lysergic Acid Diethylamide
Spencer, A. M. (1963) · The British Journal of Psychiatry · doi:10.1192/bjp.109.458.37 · Cited by 22
MicroRNA‐107 regulates anesthesia‐induced neural injury in embryonic stem cell derived neurons
Jiang, J., Zheng, X. C., Huang, F., Gao, F., You, M. Z., & Zheng, T. (2018) · IUBMB Life · doi:10.1002/iub.1911 · Cited by 22 · cited 1×
“…attenuates these effects Ketamine elicits neurotoxic effects in embryonic stem cells-derived neurons at least partially through miR-107 signaling [247] Ketamine decreases the expression of the lncRNA Long Intergenic Non-Protein Coding RNA 641 (LINC00641), leading to increased neuronal apoptosis.”
BackgroundGermann, C. B. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109406 · Cited by 22 · cited 2×
“…doses of psilocybin elicit DNA damage in the PFC [260] Hypothesis-Psilocybin might affect genetic aging via epigenetic regulation of telomere length Psilocybin might affect epigenetics processes involved with aging, preventing telomere degradation [68] A. Inserra et al. dissociation [169].”
BackgroundChen, Q., Yan, J., Xie, W., Xie, W., Li, M., & Ye, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00095 · Cited by 21 · cited 2×
“…Kinase B (Akt) signaling pathway The neurotoxic effects of high-dose ketamine in vitro might be mediated by LINC00641/miR-497-5p/BDNF signaling [214] Ketamine elicits lncRNA SPRY4 Intronic Transcript 1 (SPRY4-IT1) upregulation, dose-dependent apoptosis, and neurite degeneration in human…”
BackgroundSilva, A. S., Toffoli, L. V., Estrada, V. B., Veríssimo, L. F., de Oliveira, J. F., Moreira, E. G., Gomes, M. V., & Pelosi, G. G. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.09.007 · Cited by 20
Fluoxetine ameliorates depressive symptoms by regulating lncRNA expression in the mouse hippocampus
Zhang, C.-L., 昆明650201,中国, 中., State Key Laboratory of Phytochemistry and Plant Resources in West China, Y. K. L. O. N. M. C., Li, Y.-J., Lu, S., Zhang, T., Xiao, R., Luo, H.-R., 呼和浩特010110,中国, 内., 中国科学院大学,北京100049,中国, et al. (2021) · Zoological Research · doi:10.24272/j.issn.2095-8137.2020.294 · Cited by 20
Bisagno, V., & Cadet, J. L. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00420-3 · Cited by 20 · cited 1×
“…that psychedelics have low potential for addiction, psychological dependence or reinforcing effects, the NMDA antagonist ketamine [225, 226] and the empathogen MDMA [227, 228] have been associated with drug-seeking behaviors accompanied by epigenetic changes, similarly to drugs of abuse [229, 230].”
BackgroundHuang, C.-H., Chang, M., Lai, Y., Lin, C., Hsu, C., Tseng, B., Hsiao, C. K., Lu, T., Yu, S., Hsieh, S., et al. (2022) · Clinical Epigenetics · doi:10.1186/s13148-022-01300-z · Cited by 18 · cited 2×
“…in the mitochondrial epigenetic age of the nucleus accumbens and PFC Ketamine abuse might accelerate the mitochondrial DNA epigenetic age [216] In clinical studies in individuals with neuropathic pain, ketamine differentially modulated miRNAs expression in responders and non-responders.”
BackgroundAhmadimanesh, M., Etemad, L., Rad, D. M., Ghahremani, M. H., Mohammadpour, A. H., Esfehani, R. J., Jowsey, P. A., Behdani, F., Moallem, S. A., & Abbaszadegan, M. R. (2023) · PubMed Central · doi:10.22038/ijbms.2023.66496.14595 · Cited by 18 · cited 1×
“…such as miR-16, miR-124, miR-132, and miR-135 are implicated in antidepressant response, with drugs like fl uoxetine and venlafaxine, imipramine, sertraline, and citalopram modulating their expression, as well as the expression of miR-18a, miR-34a, miR-326, miR-1202 and miR-1971 [117, 130 – 141].”
BackgroundGrieco, S. F., Velmeshev, D., Magistri, M., Eldar-Finkelman, H., Faghihi, M. A., Jope, R. S., & Beurel, E. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1224927 · Cited by 17 · cited 2×
“Ketamine time-dependently modulated the transcription of a cluster of hippocampal (but not PFC) miRNAs (764-5p, 1912-3p, 1264-3p, 1298-5p, and 448-3p) which are hosted in the 5-HT 2C gene locus, mediated by the inhibition of glycogen synthase kinase 3 [150].”
BackgroundBarnett, B. S., Ziegler, K., Doblin, R., & Carlo, A. D. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221117536 · Cited by 16 · cited 2×
“However, subsequent experimental and epidemiological studies failed to replicate the fi ndings, even in long-term psychedelic users [261, 262].”
BackgroundLi, X., Saiyin, H., Chen, X., Yu, Q., Ma, L., & Liang, W. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01864-5 · Cited by 16 · cited 1×
“In vitro studies corroborate the neurotoxic effects of ketamine at higher doses through epigenetic mechanisms involving HDAC6, miR-22, miR-124, miR-497-5p, the lncRNAs SPRY4-IT1, LINC00641, and SNHG16, and the BDNF antisense RNA [214, 215, 237, 244 – 251].”
BackgroundIacono, L. L., Ielpo, D., Parisi, C., Napoli, G., Accoto, A., Segni, M. D., Babicola, L., D’Addario, S. L., Guzzo, S. M., Pascucci, T., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108559 · Cited by 15
Li, X.-J., Yu, J., Wu, X., Zhu, X.-M., Lv, P., Du, Z., Lü, Y., Wu, X., & Yao, J. (2022) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2022.107079 · Cited by 15 · cited 2×
“Repeated high-dose ketamine also elicited schizophrenia-like behavior accompanied by modulation of the miRNome and neurotrophic-related gene expression in the PFC and hippocampus [242, 243].”
BackgroundGuan, W., Wu, X., Jin, X., Sheng, X.-M., & Fan, Y. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230623163315 · Cited by 15
Ribeiro-Davis, A., Saeedy, D. A., Jahr, F. M., Hawkins, E., McClay, J. L., & Deshpande, L. S. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001824 · Cited by 14
Philibert, C. E., Disdier, C., Lafon, P., Bouyssou, A., Oosterlaken, M., Galant, S., Pizzoccaro, A., Tuduri, P., Ster, J., Liu, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adg1679 · Cited by 14 · cited 1×
“…given that (i) psyche-delics interact with TRKB, 5-HT 2A , and mGlu2 receptors, that (ii) TRKB interacts with the 5-HT 2A [193] and the mGlu2 [194] receptors, and that (iii) the latter two receptors interact with each other [195], these interactions may be functionally relevant from an…”
BackgroundMiRNA ‐429 alleviates ketamine‐induced neurotoxicity through targeting BAG5
Fan, X., Bian, W., Liu, M., Li, J., & Wang, Y. (2020) · Environmental Toxicology · doi:10.1002/tox.23066 · Cited by 13 · cited 2×
“Speci fi c miRNAs are responsible for the in vitro neurotoxic effects of ketamine [210] Ketamine downregulates miR-22 in PC12 cells and upregulates BAG Cochaperone 5 (BAG5) in a dose-dependent manner.”
BackgroundJakovcevski, M., Akbarian, S., & Benedetto, B. D. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.002 · Cited by 10 · cited 1×
“Brain area-and cell type-speci fi c methods, facilitated by techniques like cell-sorting approaches and single-cell omics approaches, could address these questions [264, 265].”
MethodPang, X., Su, Z., Sun, Y., Zhang, W., & Wang, H. (2018) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2018.08.005 · Cited by 10 · cited 1×
“Neuronal Differentiation 1 (NeuroD1) gene inhibition reverses the protective effect of SNHG16 on ketamine-induced neurotoxicity Ketamine elicits neuronal damage at least partially through downregulation of the lncRNA SNHG16 [246]”
BackgroundHsa-miR-605 regulates the proinflammatory chemokine CXCL5 in complex regional pain syndrome
Pande, R., Parikh, A. A., Shenoda, B. B., Ramanathan, S., Alexander, G. M., Schwartzman, R. J., & Ajit, S. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111788 · Cited by 9 · cited 2×
“Downregulating miR-605 leads to increased CXCL5 (C-X-C Motif Chemokine Ligand 5), and increased in fl ammation miR-605-mediated regulation of CXCL5 predicted the treatment response to ketamine in complex pain regional syndrome [161]”
BackgroundChoi, Y., Kim, B., Ham, S., Chung, S., Maeng, S., Kim, H.-S., & Im, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256390 · Cited by 9 · cited 2×
“…and protein phosphorylation Ketamine affects PFC miRNAs involved with transcription, and protein ubiquitination and phosphorylation in the PFC [151] A. Inserra et al. In rats with ketamine-induced conditioned place preference (CPP), thirty-four hippocampal miRNAs were differentially…”
BackgroundAndersen, P. R., Gibbs, P. R., & Kubiński, H. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90028-8 · Cited by 8
Li, X., Saiyin, H., Zhou, J.-H., Yu, Q., & Liang, W.-M. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00521-3 · Cited by 8 · cited 1×
“…dendritic spine density in medium spiny neurons in a time-and concentration-dependent manner Ketamine elicits neurotoxic effects in in vitro GABAergic neurons through HDAC6 inhibition [248] In PC12 neuronal cells, ketamine dose-dependently decreases the expression of the neuroprotective miR-429.”
BackgroundHuang, J., Xu, Y., Wang, F., Wang, H., Li, L., Deng, Y., & Cai, L. (2021) · Developmental Neuroscience · doi:10.1159/000513535 · Cited by 8 · cited 1×
“EZH2 overexpression markedly reverses the protective effects of SPRY4-IT1 knockdown on ketamine neurotoxicity The lncRNA SPRY4-IT1 is involved in the neurotoxicity elicited by ketamine in human embryonic stem cell-derived neurons, possibly through the regulation on EZH2 gene [250] Table 1. continued”
BackgroundYu, Y., Quan, J., Zou, M., Zhao, W., Su, Y., & Xu, Y. (2023) · Birth Defects Research · doi:10.1002/bdr2.2168 · Cited by 8 · cited 2×
“These effects were accompanied by altered expression of several genes related to cardiomyogenesis, resulting in enlarged heart and ventricular chamber, thinner ventricular wall, degeneration of cardiomyocytes, and reduced systolic function [218].”
BackgroundValvassori, S. S., da Rosa, R. T., Dal-Pont, G. C., Varela, R. B., Mastella, G. A., Daminelli, T., Fries, G. R., Quevedo, J., & Zugno, A. I. (2023) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10296 · Cited by 7 · cited 1×
“Repeated ketamine increased histone deacetylase and DNMT activity, in an opposite fashion to the homolog changes elicited by clinically-relevant doses [235].”
BackgroundWang, X., Li, L., Zhang, X., & Gao, J. (2021) · Human & Experimental Toxicology · doi:10.1177/09603271211051602 · Cited by 6 · cited 1×
“…effects, attenuating neurotoxicity Ketamine elicits a dose-dependent neurotoxic effect in PC12 cells, mediated by its effects on the miR-22/BAG5 [249] Ketamine at higher doses increases miR-375 expression and decreases cell viability, neurite outgrowth, and BDNF levels, while increasing ROS…”
BackgroundKetamine induces neuronal apoptosis and cognitive disorder via miR-199a-5p/HIF-1α in neonatal rats
Yan, J., Yu, Y., Sun, Y., Hu, R., & Jiang, H. (2017) · Molecular & Cellular Toxicology · doi:10.1007/s13273-017-0044-3 · Cited by 5 · cited 2×
“Additionally, repeated high-dose ketamine in young mice led to neurotoxicity, neuronal degeneration and memory impairments during adulthood, at least partially through miR-34c [236], miR-124 [237], miR-137 [238], and miR-199a-5p [239] signaling.”
BackgroundZeng, F., Wu, Q., Song, M., Kang, X.-L., Ou, Z., Yang, Z., Luo, L., & Li, D. (2023) · Human Cell · doi:10.1007/s13577-023-00972-w · Cited by 4
Filošević, A., Matić, I. S., Martinović, L. S., & Pavlić, S. D. (2024) · Future Pharmacology · doi:10.3390/futurepharmacol4010009 · Cited by 3 · cited 1×
“Brain area-and cell type-speci fi c methods, facilitated by techniques like cell-sorting approaches and single-cell omics approaches, could address these questions [264, 265].”
MethodTranscriptomic analysis of bladder tissue in a rat model of ketamine‐induced bladder fibrosis
Li, H., Li, K., Zhu, Q., Tang, Z., & Wang, Z. (2022) · Neurourology and Urodynamics · doi:10.1002/nau.24892 · Cited by 3
Levina, A. S., Shiryaeva, N. V., Vaido, A. I., & Dyuzhikova, N. A. (2013) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093013060091 · Cited by 2 · cited 1×
“Moreover, high-dose ketamine had a prophylactic effect on attenuating the stress-induced increase in hippocampal H3K9 methylation [96].”
BackgroundLi, X., Ma, G., Zhang, C., Chen, M., Huang, X., & Gu, C. (2021) · PubMed Central · Cited by 2
Levina, A. S., Shiryaeva, N. V., Vaido, A. I., & Dyuzhikova, N. A. (2013) · PubMed · Cited by 1
Cited by
Pardossi, S., Fagiolini, A., & Cuomo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313098 · Cited by 51
Psychedelics in neuroinflammation: Mechanisms and therapeutic potential
de Deus, J. L., Maia, J. M., Soriano, R. N., Amorim, M. R., & Branco, L. G. S. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111278 · Cited by 40
The science of psychedelic medicine
Siegel, J. S., Liston, C. M., Nicol, G. E., Carhart-Harris, R. L., & Bogenschutz, M. P. (2026) · Nature Medicine · doi:10.1038/s41591-025-04194-5 · Cited by 29
“It may also be possible to measure epigenetic modifications in circulating cells that reflect transcriptional programs relevant to plasticity 90,91 .”
Werle, I., & Bertoglio, L. J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105899 · Cited by 26
Psilocybin treatment extends cellular lifespan and improves survival of aged mice
Kato, K., Kleinhenz, J., Shin, Y.-J., Coarfa, C., Zarrabi, A. J., & Hecker, L. (2025) · npj Aging · doi:10.1038/s41514-025-00244-x · Cited by 22
“Priorstudieshavedemonstratedthat thelong-lastingimpactsofpsychedelictreatmentsmaybedueto epigenomic-drivenalterations,includingchromatinremodelingandDNA methylation 19 – 21 .”
Metadata
- Authors
- Inserra, A., Campanale, A., Rezai, T., Romualdi, P., & Rubino, T.
- Affiliations
- Universidade do Sul de Santa Catarina (BR)
- McGill University (CA)
- University of Bologna (IT)
- University of Insubria (IT)
- Corresponding author
- Inserra, Antonio
- Venue
- Translational Psychiatry
- Published
- 2024-09-04
- Volume
- 14
- Issue
- 1
- Pages
- 359-359
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC11375021
- OpenAlex
- W4402221259
- Cited by
- 27
- References
- 272
- Citations by year
- 2026: 11 · 2025: 14 · 2024: 2
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Translational Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IrInSubria (University of Insubria) (submittedVersion)
- Funders
- Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre
- Fonds de Recherche du Québec-Société et Culture
- Quebec Autism Research Training Program
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- rapid-acting antidepressants, epigenetics, dissociative anesthetics, psychedelics, DNA methylation, histone modifications, non-coding RNA, neuroplasticity, neurotrophism, serotonin signaling, TrkB signaling, chromatin remodeling, neuroepigenetics, depression treatment
- MeSH terms
- Animals, Antidepressive Agents, Brain, Histones, Humans, Neuronal Plasticity, Stress, Psychological, DNA Methylation, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.